Sat, Feb 28, 2015, 3:02 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • wheatusdude wheatusdude Jun 5, 2013 7:13 PM Flag

    I think I know one of Terry_amin's IDs


    Found this on the Insmed Incorporated Message Board. It's about Terry_insm who they all reckon pretends to be a share trader just to get attention. But he talks about GHDX as well. The share price is now more than $12 so he's changed his forecast from $4 to $10. Lol!

    The Stock Market is a machine for transferring wealth from investors who trust to luck to investors who understand their investments.

    And continually averaging down in a biotech in the hope of getting lucky has been the ruin of many a gullible investor.

    From the Genta board a few years ago -

    "Time to buy?

    Good to average down, especially at these prices,but I suspect lower.
    I bought last @7.19, hoping for a trade and a rally,GNTA really never saw it.
    Is our bear market rally over? Friday suggested it might be, if volume confirms this week, then have cash to buy this gem.
    Still a news driven biotech, there is always chance of a quick bubble to make money also but I stand by my... buy it, tuck it away, don't look!,come back in 2 years
    Good Luck to all Longs"

    and -

    "The stratagy works because it is after the fear,the shorts and the ride on the biotech rollercoaster.(NDA,FDA etc)

    Analysts ability to "move" a stock will be overtaken by what will be the marketplace in 2 years.(look at post 70's bear market for historical perspective) A marketplace of valuations and earnings.
    GNTA IMHO will have them....soooooooooo But it tuck it away dont'LOOK !come back in 2 years
    Good Luck to all LOngs"

    Does anybody here think the "Good luck" sign-off seems vaguely familiar?

    GNTAQ is currently trading at $0.0001. Doubtless Terry took full advantage of the numerous opportunities to average down as he rode it from $7.19 to $0.0001.

    So when a leading contender for the title of Worst Investor in Biotech offers the following warning about Insmed -

    YTD 25% "the short since stop $4"

    - give serious consideration to buying as many shares as you can possibly afford.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
30.40-0.65(-2.09%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.